Rejuvenating Endothelial Progenitor Cells Via Transcutaneous Intra-Arterial Supplementation | Clinical Trial - JUVENTAS

Description:

The goal of the trial was to evaluate treatment with repeated intra-arterial infusion of bone marrow derived mononuclear cells compared with placebo among participants with non-revascularizable limb ischemia.

Hypothesis: Repeated intra-arterial infusion of bone marrow derived mononuclear cells will reduce major amputations at 6 months.